Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
3.070
+0.210 (7.34%)
At close: Nov 6, 2026, 4:00 PM EST
3.130
+0.060 (1.95%)
After-hours: Nov 6, 2026, 4:10 PM EST
CRBP's stock price has decreased by -72.02% in the past year and price targets may not have had time to catch up.
CRBP Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $33 → $24 | Buy | Maintains | $33 → $24 | +681.76% | Oct 29, 2026 |
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +877.20% | Sep 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +1,040.07% | Sep 14, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 14, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $38 | Buy | Maintains | $38 | +1,137.79% | Sep 14, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $36 | Buy | Maintains | $36 | +1,072.64% | Aug 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $52 → $48 | Buy | Reiterates | $52 → $48 | +1,463.52% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $45 | Buy | Maintains | $45 | +1,365.80% | Jun 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.